Celiac Disease and Its Role in the Development of Metabolic Bone Disease

J Clin Densitom. 2020 Apr-Jun;23(2):190-199. doi: 10.1016/j.jocd.2019.06.005. Epub 2019 Jul 2.

Abstract

Celiac disease (CD) is an immune-mediated enteropathy that occurs in genetically susceptible hosts with the ingestion of gluten-containing products. Ongoing gluten consumption leads to intestinal damage, characterized by villous blunting and increased intraepithelial lymphocytes, resulting in malabsorption. Pertinent to the development of bone disease, malabsorption of calcium and vitamin D leads to secondary hyperparathyroidism and metabolic bone disease among individuals with CD. In this article, we review the pathogenesis of CD and the effects of malabsorption on bone health. Imbalances in bone resorption and formation particularly in individuals with CD and persistent disease activity ultimately lead to a state of bone loss and impaired mineralization. Initiation of a gluten-free diet is critical in the management of CD-related metabolic bone disease, demonstrating improvements in bone mineral density within the first year of dietary adherence.

Keywords: Bone disease; celiac disease; osteopenia; osteoporosis.

Publication types

  • Review

MeSH terms

  • Bone Density
  • Bone Diseases, Metabolic / etiology*
  • Bone Resorption / complications
  • Bone Resorption / physiopathology*
  • Calcium / metabolism
  • Celiac Disease / complications
  • Celiac Disease / diagnosis
  • Celiac Disease / diet therapy
  • Celiac Disease / physiopathology*
  • Diet, Gluten-Free
  • Humans
  • Hyperparathyroidism, Secondary / complications
  • Hyperparathyroidism, Secondary / etiology
  • Osteogenesis*
  • Osteoporosis / etiology*
  • Osteoporotic Fractures / etiology
  • Risk Factors
  • Vitamin D / metabolism

Substances

  • Vitamin D
  • Calcium